Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms

  • Riechelmann R
  • Taboada R
  • de Jesus V
  • et al.
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Neuroendocrine neoplasms (NENs) comprise a beautifully complicated, exciting landscape of histologies and clinical behaviors. However, the nuanced complexity of low- and high-grade variants can easily overwhelm both patients and providers. In this chapter, we review the ever-expanding literature on both functioning and nonfunctioning small bowel and pancreatic NENs, touching on somatostatin analogs, hepatic-directed therapies, small molecules, radiopharmaceuticals, immunotherapy, cytotoxic chemotherapy, and new promising agents. Furthermore, we suggest some strategies to address the most challenging scenarios seen in clinical practice, including sequencing of agents, treatment of carcinoid syndrome, and options for well-differentiated high-grade disease.

Cite

CITATION STYLE

APA

Riechelmann, R. P., Taboada, R. G., de Jesus, V. H. F., Iglesia, M., & Trikalinos, N. A. (2023). Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms. American Society of Clinical Oncology Educational Book, (43). https://doi.org/10.1200/edbk_389278

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free